Drug Interaction Report

Atenolol and Pioglitazone: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Atenolol

Tenormin Tenormin®
+

Pioglitazone

Actos Actos® Oseni® (as a combination product containing Alogliptin, Pioglitazone)
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 202 documented Atenolol interactions, 158 are rated moderate — including this one.
At a glance Effects may be stronger Effects may be weaker Some uncertainty
The Bottom Line
Atenolol can hide the racing-heart warning sign of low blood sugar and may shift your glucose control, so keep taking both as prescribed and let your care team monitor your sugars more closely.

You're taking atenolol (a beta-blocker for blood pressure or heart) along with pioglitazone (Actos) for diabetes. Here's what to know: beta-blockers like atenolol can hide one of the usual warning signs of low blood sugar. Normally when your sugar drops, you might feel your heart racing, but atenolol can mute that specific signal. The good news is that other warning signs, like sweating, dizziness, or shakiness, usually still come through.

Your blood sugar levels themselves may also shift a little in either direction. This is very manageable. Your care team can watch your sugars a bit more closely and adjust your diabetes medicine if needed. Keep taking both as prescribed and check in with your pharmacist or doctor.

Effect: Beta-blockade may blunt hypoglycemia awareness (specifically the adrenergic tachycardia cue) and alter glycemic control in either direction in patients on antidiabetic therapy.

  • Mechanism: Altered glucose metabolism plus beta-adrenergic blockade. Atenolol is beta-1 selective, so masking of hypoglycemic symptoms is generally less pronounced than with nonselective agents; diaphoresis and dizziness are typically preserved.
  • Direction/onset: Hypo- or hyperglycemia possible; delayed onset. Evidence: probable. Severity: moderate.
  • Management: Increase frequency of glucose monitoring; individualize pioglitazone dosing per response. Counsel on non-cardiac hypoglycemia cues. If atenolol is discontinued, watch for loss of glycemic control.
Onset
delayed
Evidence
probable
Severity
Moderate

What happens

Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia

Interaction Deep Dive

When antidiabetic medications and beta-blockers are taken together, patients may experience either hypoglycemia or hyperglycemia, and symptoms of hypoglycemia may be masked23. Tachycardia can be affected, though other hypoglycemic signs such as dizziness and sweating are not 1. Insulin-induced hypoglycemia may be intensified by nonselective beta-blockers, which can also hinder the recovery of serum glucose concentrations. In individuals who have both heart failure and diabetes, hyperglycemia may worsen 7. It may be necessary to monitor glucose more frequently or to adjust the dose of the antidiabetic drug 23. During combined use, watch carefully for signs and symptoms of hypoglycemia, and should the beta-blocker be discontinued, monitor for a loss of glycemic control 4.

Why it happens (mechanism)

Altered glucose metabolism and beta blockade

How to manage this interaction

Keep taking both medicines as prescribed unless your care team tells you otherwise. This combination is routinely managed.

  • Your team may check your blood sugar more often for a while to see how the two medicines work together.
  • Your pioglitazone dose may need to be adjusted and individualized by your care team based on your readings.
  • Learn the low-sugar signs that atenolol does not hide, such as sweating, shakiness, hunger, and dizziness.
  • Tell your doctor or pharmacist if atenolol is ever stopped, since your blood sugar control may change.

Bring any unusual readings or symptoms to your pharmacist or prescriber.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) Among elderly diabetic patients receiving either insulin or sulfonylureas, the specific antihypertensive agent selected had minimal impact on hypoglycemia risk; however, once other risk factors were accounted for, cardioselective beta blockers carried the lowest risk and non-cardioselective beta blockers the highest, while other antihypertensive medications fell in between (N=13,559) 5.

b) Beta blockers, though not alpha blockade or ACE inhibitors, produced a worsening of long-term glycemic control in patients who had hypertension together with non-insulin dependent diabetes. Beta blockade was also associated with some unfavorable changes in the lipid profile. These effects were particularly evident with propranolol. Combining an alpha blocker with the beta blocker prevented the worsening attributable to beta blockade 6.

Common questions

Can I take Atenolol and Pioglitazone together?

Atenolol can hide the racing-heart warning sign of low blood sugar and may shift your glucose control, so keep taking both as prescribed and let your care team monitor your sugars more closely. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Atenolol and Pioglitazone interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How is the Atenolol and Pioglitazone interaction managed?

Keep taking both medicines as prescribed unless your care team tells you otherwise. This combination is routinely managed. Your team may check your blood sugar more often for a while to see how the two medicines work together. Your pioglitazone dose may need to be adjusted and individualized by your care team based on your readings. Learn the low-sugar signs that atenolol does not hide, such as sw… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Atenolol or Pioglitazone need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (7)

  1. Product Information: TENORMIN(R) oral tablets, atenolol oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2012. DailyMed
  2. Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
  3. Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  4. Product Information: Glynase(R) PresTab(R) oral micronized tablets, glyburide oral micronized tablets. Pharmacia & Upjohn Co (per FDA), New York, NY, 2013. DailyMed
  5. Shorr RI, Ray WA, Daugherty JR, et al: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA 1997; 278:40-43. DOI
  6. Whitcroft IA, Thomas JM, Rawsthorne A, et al: Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics. Horm Metab Res Suppl 1990; 22:42-46.
  7. Product Information: COREG CR(R) extended-release oral capsules, carvedilol phosphate extended-release oral capsules. GlaxoSmithKline, Research Triangle Park, NC, 2011. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.